Human immunodeficiency virus-1 protease. 1. Initial velocity studies and kinetic characterization of reaction intermediates by 18O isotope exchange.

The peptidolytic reaction of HIV-1 protease has been investigated by using four oligopeptide substrates, Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2, Ac-Arg-Ala-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2, Ac-Ser-Gln-Ser-Tyr-Pro-Val-Val-NH2, and Ac-Arg-Lys-Ile-Leu-Phe-Leu-Asp-Gly-NH2, that resemble two cleavage sites found within the naturally occurring polyprotein substrates Pr55gag and Pr160gag-pol. The values for the kinetic parameters V/KEt and V/Et were 0.16-7.5 mM-1 s-1 and 0.24-29 s-1, respectively, at pH 6.0, 0.2 M NaCl, and 37 degrees C. By use of a variety of inorganic salts, it was concluded that the peptidolytic reaction is nonspecifically activated by increasing ionic strength. V/K increased in an apparently parabolic fashion with increasing ionic strength, while V was either increased or decreased slightly. From product inhibition studies, the kinetic mechanism of the protease is either random or ordered uni-bi, depending on the substrate studied. The reverse reaction or a partial reverse reaction (as measured by isotope exchange of the carboxylic product into substrate) was negligible for most of the oligopeptide substrates, but the enzyme catalyzed the formation of Ac-Ser-Gln-Asn-Tyr-Phe-Leu-Asp-Gly-NH2 from the products Ac-Ser-Gln-Asn-Tyr and Phe-Leu-Asp-Gly-NH2. The protease-catalyzed exchange of an atom of 18O from H2 18O into the re-formed substrates occurred at a rate which was 0.01-0.12 times that of the forward peptidolytic reaction. The results of these studies are in accord with the formation of a kinetically competent enzyme-bound amide hydrate intermediate, the collapse of which is the rate-limiting chemical step in the reaction pathway.

[1]  W. Cleland Determining the chemical mechanisms of enzyme-catalyzed reactions by kinetic studies. , 2006, Advances in enzymology and related areas of molecular biology.

[2]  J S Fruton,et al.  The mechanism of the catalytic action of pepsin and related acid proteinases. , 2006, Advances in enzymology and related areas of molecular biology.

[3]  V K Antonov,et al.  Studies on the mechanisms of action of proteolytic enzymes using heavy oxygen exchange. , 2005, European journal of biochemistry.

[4]  R. Dixon,et al.  Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-A resolution. , 1991, The Journal of biological chemistry.

[5]  M. Minnich,et al.  Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease. , 1991, Biochemistry.

[6]  A Wlodawer,et al.  Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor. , 1991, Biochemistry.

[7]  A Wlodawer,et al.  X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Norbeck,et al.  Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease. , 1990, Science.

[9]  T. Meek,et al.  A radiometric assay for HIV-1 protease. , 1990, Analytical biochemistry.

[10]  M. Paberit Kinetic salting effect as a promising tool in the investigation of enzyme molecule changes upon reaction: Deacylation of acyl-chymotrypsins , 1990 .

[11]  W. Farmerie,et al.  Sensitive, soluble chromogenic substrates for HIV-1 proteinase. , 1990, The Journal of biological chemistry.

[12]  G R Marshall,et al.  Hydroxyethylamine analogues of the p17/p24 substrate cleavage site are tight-binding inhibitors of HIV protease. , 1990, Journal of medicinal chemistry.

[13]  P. Kollman,et al.  Atomic charges derived from semiempirical methods , 1990 .

[14]  I B Duncan,et al.  Rational design of peptide-based HIV proteinase inhibitors. , 1990, Science.

[15]  T. Meek,et al.  Chromophoric peptide substrates for the spectrophotometric assay of HIV-1 protease. , 1990, Biochemical and biophysical research communications.

[16]  Tomi K. Sawyer,et al.  A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation. , 1990, Disease markers.

[17]  Brian W. Metcalf,et al.  Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues , 1990, Nature.

[18]  C. Debouck,et al.  Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Debouck,et al.  Recombinant HIV-1 reverse transcriptase: purification, primary structure, and polymerase/ribonuclease H activities. , 1989, Archives of biochemistry and biophysics.

[20]  M. Jaskólski,et al.  Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. , 1989, Science.

[21]  J. Sodroski,et al.  Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  B. Ho,et al.  Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity , 1989, Journal of virology.

[23]  C. Debouck,et al.  Peptide substrates and inhibitors of the HIV-1 protease. , 1989, Biochemical and biophysical research communications.

[24]  C. Debouck,et al.  Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Navia,et al.  Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1 , 1989, Nature.

[26]  Maria Miller,et al.  Crystal structure of a retroviral protease proves relationship to aspartic protease family , 1989, Nature.

[27]  D. Veber,et al.  HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins. , 1988, Biochemical and biophysical research communications.

[28]  T. Copeland,et al.  Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne) , 1988, Journal of virology.

[29]  S. Kent,et al.  Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease , 1988, Cell.

[30]  L J Davis,et al.  Active human immunodeficiency virus protease is required for viral infectivity. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[31]  C. Debouck,et al.  Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[32]  E. Padlan,et al.  Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: implications for a mechanism of action. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[33]  William R. Taylor,et al.  A structural model for the retroviral proteases , 1987, Nature.

[34]  L. Polgár The mechanism of action of aspartic proteases involves ‘push‐pull’ catalysis , 1987, FEBS letters.

[35]  J. Coligan,et al.  Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus , 1986, Journal of virology.

[36]  S. Devare,et al.  Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24 , 1985, Journal of virology.

[37]  M. James,et al.  Stereochemical analysis of peptide bond hydrolysis catalyzed by the aspartic proteinase penicillopepsin. , 1985, Biochemistry.

[38]  V. Kostka Aspartic proteinases and their inhibitors : proceedings of the FEBS advanced course no. 84/07, Prague, Czechoslovakia, August 20-24, 1984 , 1985 .

[39]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[40]  D. Davies,et al.  Three-dimensional structure of the complex of the Rhizopus chinensis carboxyl proteinase and pepstatin at 2.5-A resolution. , 1982, Biochemistry.

[41]  W. Cleland,et al.  pH variation of isotope effects in enzyme-catalyzed reactions. 1. Isotope- and pH-dependent steps the same. , 1981, Biochemistry.

[42]  S. Litwin,et al.  Correction of scrambling rate calculation for loss of substrate. , 1979, The Journal of biological chemistry.

[43]  V. Antonov,et al.  Mechanism of pepsin catalysis: General base catalysis by the active‐site carboxylate ion , 1978, FEBS letters.

[44]  T. T. Wang,et al.  Acyl and amino intermediates in reactions catalysed by pig pepsin. Analysis of transpeptidation products. , 1976, Biochemical Journal.

[45]  S. Cha,et al.  Tight-binding inhibitors-I. Kinetic behavior. , 1975, Biochemical pharmacology.

[46]  W. Cleland Partition analysis and the concept of net rate constants as tools in enzyme kinetics. , 1975, Biochemistry.

[47]  J. Knowles,et al.  Acyl- and amino-transfer routes in pepsin-catalyzed reactions , 1975 .

[48]  T. T. Wang,et al.  Acyl intermediates in pepsin and penicillopepsin catalyzed reactions. , 1974, Biochemical and biophysical research communications.

[49]  J. Knowles,et al.  The inhibition of pepsin-catalysed reactions by structural and stereochemical product analogues. , 1971, Biochemical Journal.

[50]  A. Berger,et al.  Mapping the active site of papain with the aid of peptide substrates and inhibitors. , 1970, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[51]  J. Fruton,et al.  The inhibition of pepsin action. , 1968, Biochemistry.

[52]  A. Berger,et al.  On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.

[53]  V. Potter,et al.  Enzyme Inhibition in Relation to Chemotherapy.∗ , 1949, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[54]  K. Biemann Sequencing of peptides by tandem mass spectrometry and high-energy collision-induced dissociation. , 1990, Methods in enzymology.

[55]  C. Debouck,et al.  Characterization and autoprocessing of precursor and mature forms of human immunodeficiency virus type 1 (HIV 1) protease purified from Escherichia coli , 1989, Proteins.

[56]  I. A. Rose Positional isotope exchange studies of enzyme mechanisms. , 1979, Advances in enzymology and related areas of molecular biology.

[57]  P. Deslongchamps Stereoelectronic control in the cleavage of tetrahedral intermediates in the hydrolysis of esters and amides , 1975 .

[58]  W. Cleland The kinetics of enzyme-catalyzed reactions with two or more substrates or products. I. Nomenclature and rate equations. , 1963, Biochimica et biophysica acta.